# Jasper Therapeutics, Inc.: Form 8-K/A, filed Oct 5, 2026

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K/A
- Filed: 2026-10-05
- Accepted by EDGAR: Oct 2, 2026, 18:54 ET
- Period: 2026-07-16
- Accession: 0001213900-26-106574
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390026106574/ea0307602-8ka2_jasper.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390026106574/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390026106574/ea0307602-8ka2_jasper.htm

Filed Oct 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-106574. Last ingested by Listed: Nov 4, 2026, 08:12 ET. No prices; not investment advice.